Skip to main content

Advertisement

Volume 2 Supplement 2

Symposium Mammographicum 2000

UK NHSBSP multicentre image guided biopsy trial: an interim analysis

Article metrics

  • 1498 Accesses

Full text

There are no randomised control trials (RCT) evaluating the efficacy of 11-gauge Mammotome (Ma) to 14-gauge core biopsy (CB). The aim of the study is to compare the diagnostic accuracy of the two stereotactic biopsy techniques in the diagnosis of microcalcifications and architectural distortion. A total of 600 women with impalpable clustered microcalcifications and/or distortions are prospectively recruited in a multicentre (Edgware, King's, Nottingham, Cambridge) RCT. Lesions with associated mass or density are excluded. Specimen radiographs are obtained for all biopsies performed for microcalcifications. A total of 370 women have been recruited so far and complete data for 135 women analysed. Seventy-two CB and 63 Ma had been performed on 124 microcalcifications, two distortions with microcalcifications and nine distortions. There are 34 cancers (25%) consisting of five invasive and 29 in situ carcinoma. Comparing CB and Ma, the absolute sensitivity for malignancy was 47% and 76.4%, respectively (P = 0.07) with a complete sensitivity of 76.4% and 100%, respectively (P = 0.05). CB produced more inadequate results compared to Ma (13.9% versus 4.8%, respectively; P = 0.06). Calcification retrieval was successful in 95% cases using Ma compared to 85.1% using CB (P = 0.06). The preliminary findings indicate that the use of Ma biopsy is more likely to produce a diagnostic result in the assessment of clustered microcalcifications compared to CB.

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shah, B. UK NHSBSP multicentre image guided biopsy trial: an interim analysis. Breast Cancer Res 2, A32 (2000) doi:10.1186/bcr224

Download citation

Keywords

  • Randomise Control Trial
  • Diagnostic Accuracy
  • Full Text
  • Interim Analysis
  • Core Biopsy